JOURNAL WATCH
Journal Watch
Selections from Journal Watch Pediatrics and Adolescent Medicine
| The first 150 words of the full text of this article appear below. |
Copyright © 2008 Massachussetts Medical Society. All rights reserved.
AHA STATEMENT ON CARDIOVASCULAR MONITORING IN CHILDREN WHO RECEIVE STIMULANTS
The AHAs recommendation for ECG screening in children and adolescents who take stimulant medication is premature.
The American Heart Association (AHA) released a statement on cardiovascular monitoring in children and adolescents who receive stimulant medication in which it supports electrocardiogram (ECG) monitoring as part of the evaluation. The statement is based on data from studies of various aspects of child health, including causes of sudden cardiac death (SCD) and ECG screening programs to detect underlying cardiac disease. Highlights of the report include:
- About 2.5 million children in the U.S. are prescribed stimulants for ADHD.
- From 1999 through 2003, 19 sudden deaths and 26 cardiovascular events were reported in children aged 18 years and younger who received ADHD medications.
- SCD occurs in 1000 to 7000 U.S. children annually: Causes include hypertrophic cardiomyopathy (33%–50%), long-QT syndrome (15%–25%), coronary artery anomalies (10%–20%), primary
. . . [Full text of this article]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



